doi:10.1007/s12250-021-00409-4

[1]
Shi-Zhe Xie, Mei-Qin Liu, Ren-Di Jiang, Hao-Feng Lin, Wei Zhang, Bei Li, Jia Su, Fei Ke, Qi-Ya Zhang, Zheng-Li Shi, Xing-Lou Yang, 2022: Fish ACE2 is not susceptible to SARS-CoV-2, Virologica Sinica, 37, 142-144. doi: 10.1016/j.virs.2022.01.020
[2]
Yuqi Zhu, Xinyi Yang, Jingna Xun, Jun Liu, Qing Wen, Yixiao Lin, Xiaoting Shen, Jun Chen, Songhua Yuan, Xiaying Zhao, Jing Wang, Hanyu Pan, Jinlong Yang, Zhiming Liang, Yue Liang, Qinru Lin, Huitong Liang, Min Li, Jianping Liu, Yinzhong Shen, Xiaoyan Zhang, Pengfei Wang, Daru Lu, Chunhua Yin, Jianqing Xu, Shibo Jiang, Hongzhou Lu, Huanzhang Zhu, 2022: Neutralization of five SARS-CoV-2 variants of concern by convalescent and BBIBP-CorV vaccinee serum, Virologica Sinica, 37, 831-841. doi: 10.1016/j.virs.2022.10.006
[3]
Anthony T. Tan, Joey Ming Er Lim, Antonio Bertoletti, 2022: Protection from infection or disease? Re-evaluating the broad immunogenicity of inactivated SARS-CoV-2 vaccines, Virologica Sinica, 37, 783-785. doi: 10.1016/j.virs.2022.11.002
[4]
Yang Han, Qingyu Yang, Ying Liu, Ting Shu, Li Yue, Ting Xiao, Qin Zeng, Ying Wu, Xi Zhou, Dingyu Zhang, 2020: Feasibility Study of Mixing Throat Swab Samples for Severe Acute Respiratory Syndrome Coronavirus-2 Screening, Virologica Sinica, 35, 830-832. doi: 10.1007/s12250-020-00254-x
[5]
Xiaorui Xing, Lei Wang, Zhen Cui, Wangjun Fu, Tao Zheng, Lili Qin, Pingju Ge, Aidong Qian, Nan Wang, Shuai Yuan, 2022: Structures of SARS-CoV-2 spike protein alert noteworthy sites for the potential approaching variants, Virologica Sinica, 37, 938-941. doi: 10.1016/j.virs.2022.11.003
[6]
Xiaohui Zou, Shengrui Mu, Yeming Wang, Li Guo, Lili Ren, Xiaoyan Deng, Haibo Li, Jiankang Zhao, Yulin Zhang, Hui Li, Binghuai Lu, Chaolin Huang, Bin Cao, 2022: Characterization of two SARS-CoV-2 subgenomic RNA dynamics in severe COVID-19 patients, Virologica Sinica, 37, 30-37. doi: 10.1016/j.virs.2022.01.008
[7]
Hang Yang, Huijun Yuan, Xiaohui Zhao, Meng Xun, Shangrui Guo, Nan Wang, Bing Liu, Hongliang Wang, 2022: Cytoplasmic domain and enzymatic activity of ACE2 are not required for PI4KB dependent endocytosis entry of SARS-CoV-2 into host cells, Virologica Sinica, 37, 380-389. doi: 10.1016/j.virs.2022.03.003
[8]
Yanxing Cai, Wei Xu, Chenjian Gu, Xia Cai, Di Qu, Lu Lu, Youhua Xie, Shibo Jiang, 2020: Griffithsin with A Broad-Spectrum Antiviral Activity by Binding Glycans in Viral Glycoprotein Exhibits Strong Synergistic Effect in Combination with A Pan-Coronavirus Fusion Inhibitor Targeting SARS-CoV-2 Spike S2 Subunit, Virologica Sinica, 35, 857-860. doi: 10.1007/s12250-020-00305-3
[9]
Jia Lu, Qiangling Yin, Rongjuan Pei, Qiu Zhang, Yuanyuan Qu, Yongbing Pan, Lina Sun, Ding Gao, Cuiqin Liang, Jingwen Yang, Wei Wu, Jiandong Li, Zongqiang Cui, Zejun Wang, Xinguo Li, Dexin Li, Shiwen Wang, Kai Duan, Wuxiang Guan, Mifang Liang, Xiaoming Yang, 2022: Nasal delivery of broadly neutralizing antibodies protects mice from lethal challenge with SARS-CoV-2 delta and omicron variants, Virologica Sinica, 37, 238-247. doi: 10.1016/j.virs.2022.02.005
[10]
Yi ZHANG, Wei WANG, Jin-rong GAO, Li YE, Xiao-nan FANG, Ying-chun ZENG, Zheng-hui WU, Ying-long SHE, Lin-bai YE, 2007: The Functional Motif of SARS-CoV S Protein Involved in the Interaction with ACE2, Virologica Sinica, 22, 1-7.
[11]
Ashutosh Singh, Rahul Soloman Singh, Phulen Sarma, Gitika Batra, Rupa Joshi, Hardeep Kaur, Amit Raj Sharma, Ajay Prakash, Bikash Medhi, 2020: A Comprehensive Review of Animal Models for Coronaviruses: SARS-CoV-2, SARS-CoV, and MERS-CoV, Virologica Sinica, 35, 290-304. doi: 10.1007/s12250-020-00252-z
[12]
Pingping Yao, Yachun Zhang, Yisheng Sun, Yulin Gu, Fang Xu, Bo Su, Chen Chen, Hangjing Lu, Dehui Wang, Zhangnv Yang, Biao Niu, Jiancai Chen, Lixia Xie, Lei Chen, Yajing Zhang, Hui Wang, Yuying Zhao, Yue Guo, Juncheng Ruan, Zhiyong Zhu, Zhenfang Fu, Dayong Tian, Qi An, Jianmin Jiang, Hanping Zhu, 2020: Isolation and Growth Characteristics of SARS-CoV-2 in Vero Cell, Virologica Sinica, 35, 348-350. doi: 10.1007/s12250-020-00241-2
[13]
Zaira Rehman, Massab Umair, Aamer Ikram, Ammad Fahim, Muhammad Salman, 2022: Footprints of SARS-CoV-2 genome diversity in Pakistan, 2020–2021, Virologica Sinica, 37, 153-155. doi: 10.1016/j.virs.2022.01.009
[14]
Sissy Therese Sonnleitner, Stefanie Sonnleitner, Eva Hinterbichler, Hannah Halbfurter, Dominik B.C. Kopecky, Stephan Koblmüller, Christian Sturmbauer, Wilfried Posch, Gernot Walder, 2022: The mutational dynamics of the SARS-CoV-2 virus in serial passages in vitro, Virologica Sinica, 37, 198-207. doi: 10.1016/j.virs.2022.01.029
[15]
Ge Gao, Xue Hu, Yiwu Zhou, Juhong Rao, Xiaoyu Zhang, Yun Peng, Jiaxuan Zhao, Yanfeng Yao, Kunpeng Liu, Mengying Liang, Hang Liu, Fei Deng, Han Xia, Chao Shan, Zhiming Yuan, 2022: Infection and pathogenesis of the Delta variant of SARS-CoV-2 in Rhesus macaque, Virologica Sinica, 37, 299-302. doi: 10.1016/j.virs.2022.02.001
[16]
Wei Chen, Pengmian Feng, Kewei Liu, Meng Wu, Hao Lin, 2020: Computational Identification of Small Interfering RNA Targets in SARS-CoV-2, Virologica Sinica, 35, 359-361. doi: 10.1007/s12250-020-00221-6
[17]
Mengying Liang, Wanbo Tai, Yunyun Wang, Yulong Dai, Yanfeng Yao, Juan Min, Yiwu Zhou, Liang Liu, Chao Shan, Han Xia, Zhiming Yuan, 2022: SARS-CoV-2 infection induces testicular injury in Rhesus macaque, Virologica Sinica, 37, 934-937. doi: 10.1016/j.virs.2022.10.008
[18]
Kai Wu, Dehe Wang, Junhao Wang, Yu Zhou, 2022: Translation landscape of SARS-CoV-2 noncanonical subgenomic RNAs, Virologica Sinica, 37, 813-822. doi: 10.1016/j.virs.2022.09.003
[19]
Changhua Yi, Yongxiang Yi, Junwei Li, 2020: mRNA Vaccines: Possible Tools to Combat SARS-CoV-2, Virologica Sinica, 35, 259-262. doi: 10.1007/s12250-020-00243-0
[20]
Xiao Hu, Zhen Chen, Zhengyuan Su, Fei Deng, Xinwen Chen, Qi Yang, Pan Li, Quanjiao Chen, Jun Ma, Wuxiang Guan, Rongjuan Pei, Yun Wang, 2021: Ozone Water Is an Effective Disinfectant for SARS-CoV-2, Virologica Sinica, 36, 1066-1068. doi: 10.1007/s12250-021-00379-7